- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 110.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 106.99M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $5.66M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $45.52M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $62.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $59.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $57.18M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $30.01M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $36.24M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $51.58M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $58.87M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $80.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $84.92M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $186.41M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $190.67M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $19.06M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $16.67M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8.73M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $9.72M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.17M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.65M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $199K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $2.65M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.24M |
| Revenue | Q1 2026 · Mar 31, 2026 | $43.56M |
| Revenue | Q1 2026 · Mar 31, 2025 | $44.61M |